Copyright © Philip M. Parker, INSEAD. Terms of Use.
| Domain | Definition |
Health | Fibrinogens which have a functional defect as the result of one or more amino acid substitutions in the amino acid sequence of normal fibrinogen. Abnormalities of the fibrinogen molecule may impair any of the major steps involved in the conversion of fibrinogen into stabilized fibrin, such as cleavage of the fibrinopeptides by thrombin, polymerization and cross-linking of fibrin. The resulting dysfibrinogenemias can be clinically silent or can be associated with bleeding, thrombosis or defective wound healing. (references) |
Source: compiled by the editor from various references; see credits. | |
Hexadecimal (or equivalents, 770AD-1900s) (references)46 49 42 52 49 4E 4F 47 45 4E 53 2C 41 42 4E 4F 52 4D 41 4C |
| Leonardo da Vinci (1452-1519; backwards) (references)
|
Binary Code (1918-1938, probably earlier) (references)01000110 01001001 01000010 01010010 01001001 01001110 01001111 01000111 01000101 01001110 01010011 00101100 00100000 01000001 01000010 01001110 01001111 01010010 01001101 01000001 01001100 |
HTML Code (1990) (references)F I B R I N O G E N S ,   A B N O R M A L |
ISO 10646 (1991-1993) (references)0046 0049 0042 0052 0049 004E 004F 0047 0045 004E 0053 002C 0041 0042 004E 004F 0052 004D 0041 004C |
Encryption (beginner's substitution cypher): (references)40433652434849413948531423536484952473546 |
| 1. Orthography 2. Bibliography |
Copyright © Philip M. Parker, INSEAD. Terms of Use.
